Takami Sato

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Venues

Cancers

Science signaling

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

Thomas Jefferson University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Thomas Jefferson University

United States

Professor :: Medical Oncology

Publications

Vivian Chua, Melisa Lopez-Anton, Mizue Terai, Ryota Tanaka, Usman Baqai, Timothy J Purwin, Jelan I Haj, Francis J Waltrich, Isabella V Trachtenberg, Kristine Luo, Rohith Tudi, Angela Jeon, Anna Han, Inna Chervoneva, Michael A Davies, Julio A Aguirre-Ghiso, Takami Sato, Andrew E Aplin
Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress. Science signaling 17 (840) (2024)
Vivian Chua, Melisa Lopez-Anton, Mizue Terai, Ryota Tanaka, Usman Baqai, Timothy J Purwin, Jelan I Haj, Francis J Waltrich, Isabella V Trachtenberg, Kristine Luo, Rohith Tudi, Angela Jeon, Anna Han, Inna Chervoneva, Michael A Davies, Julio A Aguirre-Ghiso, Takami Sato, Andrew E Aplin
Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress. Science signaling 17 (840) (2024)
Vivian Chua, Melisa Lopez-Anton, Mizue Terai, Ryota Tanaka, Usman Baqai, Timothy J Purwin, Jelan I Haj, Francis J Waltrich, Isabella V Trachtenberg, Kristine Luo, Rohith Tudi, Angela Jeon, Anna Han, Inna Chervoneva, Michael A Davies, Julio A Aguirre-Ghiso, Takami Sato, Andrew E Aplin
Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress. Science signaling 17 (840) (2024)
Vivian Chua, Melisa Lopez-Anton, Mizue Terai, Ryota Tanaka, Usman Baqai, Timothy J Purwin, Jelan I Haj, Francis J Waltrich, Isabella V Trachtenberg, Kristine Luo, Rohith Tudi, Angela Jeon, Anna Han, Inna Chervoneva, Michael A Davies, Julio A Aguirre-Ghiso, Takami Sato, Andrew E Aplin
Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress. Science signaling 17 (840) (2024)
Anna Han, Dzmitry Mukha, Vivian Chua, Timothy J Purwin, Manoela Tiago, Bhavik Modasia, Usman Baqai, Jenna L Aumiller, Nelisa Bechtel, Emily Hunter, Meggie Danielson, Mizue Terai, Philip B Wedegaertner, Takami Sato, Solange Landreville, Michael A Davies, Stefan Kurtenbach, J William Harbour, Zachary T Schug, Andrew E Aplin
Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth. Cancers 15 (13) (2023)
Richard D Carvajal, Paul D Nathan, Joseph J Sacco, Marlana Orloff, Leonel F Hernandez-Aya, Jessica Yang, Jason John Luke, Marcus O Butler, Sarah Stanhope, Laura Collins, Cheryl McAlpine, Chris Holland, Shaad E Abdullah, Takami Sato
Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (17) (2022)
Diwakar Davar, Roberta Zappasodi, Hong Wang, Girish S Naik, Takami Sato, Todd Bauer, David L Bajor, Olivier Rixe, Walter Newman, Jingjing Qi, Aliya Holland, Phillip Wong, Lianna Sifferlen, Diane Piper, Cynthia A Sirard, Taha Merghoub, Jedd D Wolchok, Jason John Luke
Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra P Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason J Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Howard M Goodall, Koustubh Ranade, Chris Holland, Shaad E Abdullah, Joseph J Sacco, Takami Sato
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial. Nature medicine 28 (11) (2022)
Dominic Lapadula, Bao Lam, Mizue Terai, Tsuyoshi Takahashi, Ryota Tanaka, Eduardo F Farias, Rama Kadamb, Melissa Lopez-Anton, Christian C Heine, Bhavik Modasia, Julio A Aguirre-Ghiso, Andrew E Aplin, Takami Sato, Jeffrey L Benovic
IGF1R inhibition enhances the therapeutic effects of Gq/11 inhibition in metastatic uveal melanoma progression. Molecular cancer therapeutics (2022)
Mizue Terai, Ayako Shimada, Inna Chervoneva, Liam Hulse, Meggie Danielson, Jeff Swensen, Marlana Orloff, Philip B Wedegaertner, Jeffrey L Benovic, Andrew E Aplin, Takami Sato
Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma. Cancers 13 (22) (2021)
Justine S Paradis, Monica Acosta, Robert Saddawi-Konefka, Ayush Kishore, Frederico Gomes, Nadia Arang, Manoela Tiago, Silvia Coma, Simone Lubrano, Xingyu Wu, Kyle Ford, Chi-Ping Day, Glenn Merlino, Prashant Mali, Jonathan A Pachter, Takami Sato, Andrew E Aplin, J Silvio Gutkind
Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Ryota Tanaka, Mizue Terai, Eric Londin, Takami Sato
The Role of HGF/MET Signaling in Metastatic Uveal Melanoma. Cancers 13 (21) (2021)
Masahiro Ohara, Kengo Saito, Ken Kageyama, Mizue Terai, Hanyin Cheng, Andrew E Aplin, Takami Sato
Dual Targeting of CDK4/6 and cMET in Metastatic Uveal Melanoma. Cancers 13 (5) (2021)
Rino S Seedor, Marlana Orloff, Takami Sato
Genetic Landscape and Emerging Therapies in Uveal Melanoma. Cancers 13 (21) (2021)
Jessica L F Teh, Timothy J Purwin, Anna Han, Vivian Chua, Prem Patel, Usman Baqai, Connie Liao, Nelisa Bechtel, Takami Sato, Michael A Davies, Julio Aguirre-Ghiso, Andrew E Aplin
Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal Melanoma. Molecular cancer therapeutics 19 (8) (2020)

Takami Sato.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Takami Sato